Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

View source ↗

Summary

This completed study evaluated the safety and persistence of genetically modified white blood cells in HIV-infected individuals using an identical twin pairs de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Status: COMPLETED